18. Monoclonal Antibodies as Biopharmaceuticals

  1. Yashwant Pathak3 and
  2. Simon Benita4
  1. Girish J. Kotwal

Published Online: 23 APR 2012

DOI: 10.1002/9781118229019.ch18

Antibody-Mediated Drug Delivery Systems: Concepts, Technology, and Applications

Antibody-Mediated Drug Delivery Systems: Concepts, Technology, and Applications

How to Cite

Kotwal, G. J. (2012) Monoclonal Antibodies as Biopharmaceuticals, in Antibody-Mediated Drug Delivery Systems: Concepts, Technology, and Applications (eds Y. Pathak and S. Benita), John Wiley & Sons, Inc., Hoboken, NJ, USA. doi: 10.1002/9781118229019.ch18

Editor Information

  1. 3

    Department of Pharmaceutical Sciences, College of Pharmacy, University of South Florida, Tampa, Florida, USA

  2. 4

    The Institute for Drug Research of the School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel

Author Information

  1. Kotwal Bioconsulting, LLC and InFlaMed, Inc., Louisville, Kentucky, USA

  1. University of Medicine and Health Sciences, St. Kitts, WI

Publication History

  1. Published Online: 23 APR 2012
  2. Published Print: 11 MAY 2012

ISBN Information

Print ISBN: 9780470612811

Online ISBN: 9781118229019

SEARCH

Keywords:

  • monoclonal antibodies as biopharmaceuticals;
  • structure and types of mAbs, mechanism of action;
  • FDA-approved mAb biopharmaceuticals in current use;
  • bioprocessing market share of monoclonal antibodies;
  • therapeutic mAb market, a rapid rise

Summary

This chapter contains sections titled:

  • Historical Perspective

  • Introduction

  • Structure and Types of mAbs

  • Mechanism of Action

  • FDA-approved mAb Biopharmaceuticals in Current Use

  • Future of Monoclonal Antibodies as Biopharmaceuticals

  • References